Abu Dhabi’s Cleveland Clinic has achieved a medical breakthrough by performing the United Arab Emirates’ inaugural robotic-assisted stereoelectroencephalography (SEEG) procedure, revolutionizing the diagnostic approach to complex epilepsy cases. This advanced technique represents a substantial leap forward in neurological care, building upon the hospital’s previous accomplishment of the nation’s first non-robotic SEEG performed just last year.
The innovative robotic SEEG methodology replaces traditional frame-based systems that required rigid head frames fixed directly to patients’ skulls—an often uncomfortable and time-intensive process. Instead, this minimally invasive approach utilizes robotic precision to implant delicate electrodes into targeted brain regions, enabling physicians to monitor electrical activity and pinpoint the exact origin of epileptic seizures with unprecedented accuracy.
Medical executives at Cleveland Clinic Abu Dhabi emphasize that this technological advancement transcends mere equipment acquisition. Dr. Georges-Pascal Haber, Chief Executive Officer, stated: ‘We are providing epilepsy patients with access to safer, more precise diagnostics that can fundamentally transform their treatment pathways. Our investment in neurological innovation enables brain understanding at previously impossible levels.’
The institution has already successfully completed three procedures since implementing the robotic technology, demonstrating both its clinical viability and growing impact. According to Dr. Florian Roser, Chief Medical Officer and Institute Chief of the Neurological Institute, the technique allows for personalized approaches tailored to each patient’s unique brain anatomy, significantly enhancing diagnostic accuracy while facilitating better-informed treatment strategies.
This medical milestone reinforces Abu Dhabi’s position at the forefront of minimally invasive neurological treatments and reflects the UAE’s broader commitment to healthcare innovation that prioritizes patient safety, comfort, and superior clinical outcomes.









